FindTrial
Sign In

Observational cohort study of clinically diagnosed unresectable pancreatic cancer patients; A multicenter retrospective, questionnaire analysis in Hokkaido Pancreatic Cancer Study Group (HOPS).

Observational cohort study of clinically diagnosed unresectable pancreatic cancer patients; A multicenter retrospective, questionnaire analysis in Hokkaido Pancreatic Cancer Study Group (HOPS). - HOPS-UR

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000035454
Enrollment
66
Registered
2019-01-05
Start date
2016-06-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic adenocarcinoma (PDAC), unresectable (UR)

Interventions

None listed

Sponsors

Department of Surgery, Surgical Oncology and Science, Sapporo Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who were defined as unersectable (UR-) and were ineligible for these two studies by HOPS central MDCT review. 2) Pathologically or cytologically proven diagnosis of pancreas cancer. 3) Patients of age =>20 4) Performance Status:0-1 (ECOG) 5) Adequate oral intake 6) Good main organ function

Exclusion criteria

Exclusion criteria: Patients who were defined as resectable (R-) or borderline resectable (BR-) by HOPS central MDCT review.

Design outcomes

Primary

MeasureTime frame
Conversion rate to radical surgeries—

Secondary

MeasureTime frame
Sequential treatment regimens and overall survival (OS)—

Countries

Japan

Contacts

Public ContactYasutoshi Kimura

Sapporo Medical University Department of Surgery, Surgical Oncology and Science

kimuray@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026